Neurophet Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Public

  • Employees
  • 135

Employees

  • Stock Symbol
  • 380550

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $3.72
  • (As of Friday Closing)

Neurophet General Information

Description

Neurophet Inc is engaged in developing brain disease artificial intelligence (AI) solutions. The company's services include: Imaging Core Lab; Design System Consulting; and QMS Consulting.

Contact Information

Website
www.neurophet.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Samwon Tower 12th Floor
  • 124 Teheran-ro, Gangnam-gu
  • Seoul, 06234
  • South Korea
+82
Primary Industry
Decision/Risk Analysis
Stock Exchange
KRX
Vertical(s)
Artificial Intelligence & Machine Learning, TMT, Life Sciences
Corporate Office
  • Samwon Tower 12th Floor
  • 124 Teheran-ro, Gangnam-gu
  • Seoul, 06234
  • South Korea
+82

Neurophet Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurophet Stock Performance

As of 13-Nov-2026, Neurophet’s stock price is $3.72. Its current market cap is $45.3M with 12.2M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.72 $3.99 $3.59 - $25.26 $45.3M 12.2M 186K -$1.35

Neurophet Financials Summary

As of 30-Jun-2026, Neurophet has a trailing 12-month revenue of $1.78M.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 75,002 163,471
Revenue 1,784 1,838 1,624 1,195
EBITDA (15,616) (14,596) (7,961) 6,378
Net Income (15,865) (15,732) (11,068) 4,025
Total Assets 32,465 18,670 6,694 17,954
Total Debt 4,245 3,840 876 1,439
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Neurophet Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Neurophet‘s full profile, request access.

Request a free trial

Neurophet Patents

  • 127

    Total Documents Applications and Grants

  • Total Patents Families

  • 90

    Granted

  • 13

    Pending

  • Expiring in next 12 mo

Neurophet Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026089196-A1 Apparatus and method for analyzing brain image Pending 21-Oct-2024
WO-2025230066-A1 System and method for predicting brain age of infant or toddler by using brain image Pending 03-May-2024
EP-4358094-A1 Device and method for redesigning treatment prescription according to evaluation of therapeutic effectiveness Active 31-Aug-2022
EP-4358094-A4 Device and method for redesigning treatment prescription according to evaluation of therapeutic effectiveness Active 31-Aug-2022
WO-2024048836-A1 Device and method for redesigning treatment prescription according to evaluation of therapeutic effectiveness Inactive 31-Aug-2022 G16H20/10
To view Neurophet’s complete patent history, request access »

Neurophet Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurophet Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Neurophet‘s full profile, request access.

Request a free trial

Neurophet Investments (1)

Neurophet’s most recent deal was a Joint Venture with Joint venture (Beijing LADO Technology / Neurophet). The deal was made on 30-Oct-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Joint venture (Beijing LADO Technology / Neurophet) 30-Oct-2024 Joint Venture Media and Information Services (B2B)
To view Neurophet’s complete investments history, request access »

Neurophet ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Software & Services

Industry

Rank

Percentile

Enterprise and Infrastructure Software

Subindustry

Rank

Percentile

To view Neurophet’s complete esg history, request access »

Neurophet FAQs

  • When was Neurophet founded?

    Neurophet was founded in 2015.

  • Where is Neurophet headquartered?

    Neurophet is headquartered in Seoul, South Korea.

  • What is the size of Neurophet?

    Neurophet has 135 total employees.

  • What industry is Neurophet in?

    Neurophet’s primary industry is Decision/Risk Analysis.

  • Is Neurophet a private or public company?

    Neurophet is a Public company.

  • What is Neurophet’s stock symbol?

    The ticker symbol for Neurophet is 380550.

  • What is the current stock price of Neurophet?

    As of 13-Nov-2026 the stock price of Neurophet is $3.72.

  • What is the current market cap of Neurophet?

    The current market capitalization of Neurophet is $45.3M.

  • What is Neurophet’s current revenue?

    The trailing twelve month revenue for Neurophet is $1.78M.

  • What is Neurophet’s annual earnings per share (EPS)?

    Neurophet’s EPS for 12 months was -$1.35.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process